John Patrick Oroho, D. Jeffrey Campbell, and Anne E. Wagstaff of Porzio Pharmaceutical Services will attend the Summit on disclosure, transparency and aggregate spend for drug, device and biotech companies.  Mr. Oroho will also participate in an Aggregate Spend Technology Solution Provider Roundtable at 2 p.m. on the second day of the Summit.
 

Conference sessions will focus on best practices for preparing for Sunshine Act requirements, including the development of operational policies and procedures, as well as technological solutions for aggregate spend compliance. 

For information on attending the conference in person or online via live feed, click here.

Washington , DC